glp 1 agonist weight loss mechanism GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes Mechanisms by which GLP-1 agonists

Real-world evidence (RWE) was a major contributor in uncovering some of these unexpected benefits

doi: 10.3748/wjg.v24.i30.3361 4 MarjotTMoollaACobboldJFHodsonLTomlinsonJW

Reduces Cravings in 30 Days Fewer sweet and salty snack attacks

Lixisenatide (ADLYXIN) Phonetic pronunciation: LIX i SEN a tide / ad LIX in Mnemonic: Add licks in a Tide (Pod) Year of release: 2016 Price range: $690$710 FDA-approved for: Type 2 diabetes Mechanism: GLP-1 receptor agonist Available doses: 10 mcg, 20 mcg Dynamic interactions: Glucose lowering Kinetic interactions: Delayed gastric emptying, otherwise none in a bubble Lixisenatide (Adlyxin) is the newer exendin-based GLP analog

Multiple drugs within this class have been approved for T2D management since the mid-2000s